Presentations in biology – Renata Veselska

PUBLIC LECTURES:

Veselska R: Vědecká integrita [Scientific Integrity]. Webinar for Ethics in Research series, ICRC, St. Anne’s University Hospital, Brno, March 18, 2021.
Veselska R: Etika biomedicínského výzkumu [Ethics of Biomedical Research]. Webinar for Ethics in Research series, ICRC, St. Anne’s University Hospital, Brno, March 11, 2021.
Veselska R: Etika biomedicinskeho vyzkumu: Blizka setkani tretiho druhu [Ethics of Biomedical Research: Close Encounters of the Third Kind]. Jednota filozoficka Brno, April 9th, 2018 (Faculty of Arts, Masaryk University, Brno, CZ).
Veselska R: Don’t Panic: The Hitchhiker’s Guide to the Research Ethics. CEITEC PhD Retreat II, April 20th, 2017 (University Centre, Telc, CZ).
Veselska R, Kure J: Vse, co jste kdy chteli vedet o bioetice* (* ale bali jste se zeptat) [Everything you always wanted to know about bioethics* (* but were afraid to ask)] Seminar of the Center of Experimental Biomedicine, December 4th, 2014 (University Campus Bohunice, Brno, CZ).
Veselska R: Nadorove kmenove bunky. [Cancer stem cells.] Contipro Seminar „Stem Cells in Disease and Therapy“ (Contipro Holding, Dolni Dobrouc, CZ).
Veselska R: Dilemata na cipech: eticke aspekty praktickeho pouzivani novych diagnostickych technologii. [Dilemmas on microarrays: ethical aspects related to the practical use of new diagnostic technologies.] 16th Conference on DNA Diagnostics, Brno, November 28th, 2012, Mendel’s Refectory (Augustinian Abbey in Old Brno, Brno, CZ).
Veselska R: Lekce z historie: od Mendelovych zakonu k eugenice. [Lessons from history: from Mendel’s law to eugenics.] Conference Mendelian Inheritance in Medical Genetics, May 28th, 2012, Mendel’s Refectory (Augustinian Abbey in Old Brno, Brno, CZ).
Veselska R: Existuji zlocinecke geny? (Vyzkum genetickych predispozic ke kriminalnimu chovani a souvisejici eticka dilemata o zlocinu a trestu) [Criminal genes: do they exist?] Lecture associated to the exhibition Stopa, April 10th, 2012, Mendel Museum (Augustinian Abbey in Old Brno, Brno, CZ).
Veselska R: Veda a svedomi. [Science and conscience.] Conference TEDx Brno 2011, November 12th, 2011, Reduta Theater (Brno, CZ).
Veselska R: GMO mezi nami – pycha ci predsudek? [GMOs among us – pride or prejudice?] Series GMOs – Myths and Legends, April 8th, 2010, Mendel’s Refectory (Augustinian Abbey in Old Brno, Brno, CZ).
Veselska R: Majitele nasich genu – Eticke aspekty pristupu k informacim a patentovani v biologii a v medicine. [Owners of our genes – Ethical aspects of the information accessibity and patent issues in biology and medicine.] Series GEN-ETHICS, June 7th, 2006, Mendel’s Refectory (Augustinian Abbey in Old Brno, Brno, CZ).
Veselska R: Dinosauri a zlata ryze – Eticke aspekty genetickych modifikaci. [Dinosaurs and golden rice – Ethical aspects of genetic modifications.] Series GEN-ETHICS, May 24th, 2006, Mendel’s Refectory (Augustinian Abbey in Old Brno, Brno, CZ).
Veselska R: Ta podoba, cely tatinek! – Eticke aspekty reprodukcni biologie. [The baby looks like daddy! – Ethical aspects of reproductive biology.] Series GEN-ETHICS, May 10th, 2006, Mendel’s Refectory (Augustinian Abbey in Old Brno, Brno, CZ).

PUBLISHED ABSTRACTS AND CONFERENCE PRESENTATIONS:

Veselska R: Embryo in a Dish: Many Ways, One Outcome. 30th NEC Forum (on-line), Prague 2022.
Chlapek P, Mahdal M, Staniczkova Zambo I, Paukovcekova S, Veselska R, Neradil J: Analysis of RTK signaling in giant cell tumor of bone. In: 62nd Annual Meeting of the Italian Cancer Society – Abstract Book (Venice, Italy), p.128, 2022.
Neradil J, Mahdal M, Mudry P, Staniczkova Zambo I, Chlapek P, Veselska R: PDGFR beta targeting in the treatment of giant cell tumor of bone. In: 62nd Annual Meeting of the Italian Cancer Society – Abstract Book (Venice, Italy), p.129, 2022.
Veselska R: Etické aspekty genových terapií. 24. Brněnské setkání dětských neurologů a pediatrů, Brno 2022.
Veselska R: Etika výzkumu v ČR, rok 2022: samozřejmost, formalita nebo přežitek? XXV. Biologické dny: Od nádorové biologie po precizní onkologii, Brno 2022.
Krchniakova M, Paukovcekova S, Chlapek P, Neradil J, Skoda J, Veselska R: Tyrosine kinase inhibitors synergize with thiosemicarbazones in neuroblastoma cells and converge on impaired pro-survival signaling and NDRG1 upregulation. Book of Abstracts: The Biomania Student Scientific Meeting (Brno, Czech Republic), p. 124, 2022.
Curylová L, Neradil J, Štěrba J, Veselská R, Škoda J. Vztah mezi expresí proteinů signální dráhy p53 a faktorů kmenovosti u sarkomů dětského věku. XXVI. Brněnské onkologické dny. Klin Onkol. 2021; 34(Suppl 2): 2S98.
Vaskova A, Neradil J, Chlapek P, Veselska R. NTRK signaling analysis in neuroblastoma cell lines. EMBL Conference: Cancer genomics. 22-24 Nov 2021. (on-line)
Mikulenkova E, Kozlova V, Smida M, Veselska R: Association of deltaNp73 isoform expression with centrosome amplification in tumor cell lines of neurogenic origin. In: International p53/p63/p73 Isoforms Workshop – Book of abstracts (Dubrovnik, Croatia), pp. 111-112, 2019.
Neradil J, Kyr M, Polaskova K, Kren L, Skoda J, Sterba J, Veselska R: Phospho-protein arrays: a useful tool for identification of kinase inhibitors targets in personalized treatment of pediatric refractory solid tumors. NCRI Cancer Conference (Glasgow, UK), 2019.
Krchniakova M, Neradil J, Chovanova S, Chlapek P, Richardson DR, Sterba J, Veselska R: Combining tyrosine kinase inhibitors with novel thiosemicarbazone iron chelators in cell lines derived from pediatric solid tumors of neurogenic origin. NCRI Cancer Conference (Glasgow, UK), 2019.
Borankova K, Neradil J, Hogarty M, Veselska R, Skoda J: Inhibition of Mitochondrial Fission and Protein Synthesis Efficiently Induces Apoptosis in Stem-Like Drug-Resistant Neuroblastoma Cells. In: Mitochondria in Life, Death and Disease – Abstract Book (Herceg Novi, Montenegro), p. 36, 2019.
Macigova P, Neradil J, Polaskova K, Kyr M, Mudry P, Sterba J, Veselska R: The importance of personalized approach in the therapy of pediatric patients with high-risk CNS tumors. In: Brain Tumor Meeting 2019 – Book of Abstracts (Berlin, Germany), p. 69, 2019.
Krchniakova M, Neradil J, Chovanova S, Chlapek P, Richardson DR, Sterba J, Veselska R: Effects of tyrosine kinase inhibitors combined with novel thiosemicarbazone iron chelators on cell lines derived from pediatric solid tumors. In: Book of Abstracts: The Biomania Student Scientific Meeting & EUSynBioS Symposium (Brno, Czech Republic), p. 50, 2019.
Curylova L, Chlapek P, Skoda J, Veselska R: Potential modulation of cancer stem cell phenotype in neuroblastoma using retinoids. In: Book of Abstracts: The Biomania Student Scientific Meeting & EUSynBioS Symposium (Brno, Czech Republic), p. 90, 2019.
Borankova K, Neradil J, Hogarty M, Veselska R, Skoda J: Targeting Mitochondrial Protein Synthesis by Doxycycline Inhibits the Activity of Mitochondrial Fission-Related Protein DRP1 and Induces Apoptosis in Neuroblastoma. In: Book of Abstracts: The Biomania Student Scientific Meeting & EUSynBioS Symposium (Brno, Czech Republic), p. 88, 2019.
Krchniakova M, Neradil J, Chovanova S, Chlapek P, Richardson DR, Sterba J, Veselska R: Combined treatment in pediatric solid tumors of neurogenic origin using tyrosine kinase inhibitors and thiosemicarbazone iron chelators. In: XLIII. Brnenske onkologicke dny – Sbornik abstrakt (Brno, CZ), Klin Onkol 32 (Suppl 1), S20, 2019.
Neradil J, Polaskova K, Macigova P, Mudry P, Veselska R, Sterba J: Identification of receptor tyrosine kinases and downstream signaling pathways as possible therapeutic targets using phosphoprotein arrays. EACR-AACR-ISCR Conference: The Cutting Edge of Contemporary Cancer Research (Jerusalem, Israel), 2018.
Chovanova S, Chlapek P, Sterba J, Richardson DR, Veselska R: Synergistic effects of novel thiosemicarbazones and selected anticancer drugs on cells of rare pediatric solid tumors. EACR-AACR-ISCR Conference: The Cutting Edge of Contemporary Cancer Research (Jerusalem, Israel), 2018.
Dobrotkova V, Chlapek P, Adamkova K, Jezova M, Mazanek P, Sterba J, Veselska R: Analysis of putative biomarkers of resistance to retinoids in neuroblastoma cells and tumor tissue samples. NCRI Cancer Conference (Glasgow, UK), 2018.
Chovanova S, Krchniakova M, Chlapek P, Sterba J, Richardson DR, Veselska R: Therapeutic potential of novel thiosemicarbazones in pediatric oncology: combined treatment with vinca alkaloids. NCRI Cancer Conference (Glasgow, UK), 2018.
Mikulenkova E, Neradil J, Skoda J, Veselska R: Atypical centrosomal localization of Nanog protein. In: 20th EMBL PhD Symposium GAME CHANGERS: Taking Life Sciences to the Next Level (Heidelberg, Germany), p. 103, 2018.
Macigova P, Neradil J, Polaskova K, Kyr M, Mudry P, Sterba J, Veselska R: The use of protein arrays in targeted therapy – differences in signaling between neuroblastoma tumor samples and cell lines. In: 3rd EACR Conference Making it Personal: Cancer Precision Medicine (Bergamo, Italy), p. 71, 2018.
Chovanova S, Krchniakova M, Chlapek P, Sterba J, Richardson DR, Veselska R: Synergictic effects of anthracyclines and novel thiosemicarbazones on cell lines derived from pediatric solid tumors. In: Mechanisms to Therapies: Innovations in Cancer Metabolism: Programme Book (Bilbao, Spain), p. 72, 2018.
Chlapek P, Slavikova V, Adamkova K, Jezova M, Mazanek P, Sterba J, Veselska R: Resistance to retinoids – analysis of putative biomarkers in neuroblastoma cells and tumour tissue samples. In: ESMO Open 3(Suppl 2) – 25th Biennial Congress of the European Association for Cancer Research (Amsterdam, Netherlands), p. A104, 2018.
Ladungova A, Chlapek P, Chovanova S, Richardson D.R., Veselska R: Terapeuticky potencial novych thiosemicarbazonovv bunkach rabdomyosarkomu. In: XLII. Brnenske onkologicke dny – Sbornik abstrakt (Brno, CZ), Klin Onkol 31 (Suppl 1), S115 – S116, 2018.
Veselska R: Research Ethics Committee of the Masaryk University: The First Year Experience. Transcending Borders: Building and Sustaining a Bioethics Network for Low- and Middle-Income Countries (Riga, Latvia), 2017.
Chlapek P, Slavikova V, Adamkova K, Jezova M, Mazanek P, Sterba J, Veselska R: Expression of putative protein markers related to the sensitivity or resistance to retinoids in neuroblastoma tumor tissue samples and tumor-derived cell lines. In: FEBS Journal 284 (Suppl. 1) – 42nd Congress of the Federation-of-European-Biochemical-Societies (FEBS) on From Molecules to Cells and Back (Jerusalem, Israel), p. 4.1-113, 2017.
Neradil J, Macigova P, Sramek M, Melicharkova K, Mudry P, Veselska R, Sterba J: Identification of receptor tyrosine kinases and downstream signaling pathways as possible therapeutic targets using phosphoprotein arrays. In: Pediatric Blood & Cancer 64 (Suppl. 3) – Meeting Abstract P-522; 49th Congress of the International Society of Paediatric Oncology (Washington DC, USA), p. S404, 2017.
Veselska R, Sramek M, Neradil J, Macigova P, Mudry P, Melicharkova K, Slaby O, Vanackova J, Sterba J: Aberrant PDGFR signaling as a target for treatment of the infantile myofibromatosis with sunitinib. In: Pediatric Blood & Cancer 64 (Suppl. 3) – Meeting Abstract P-287; 49th Congress of the International Society of Paediatric Oncology (Washington DC, USA), p. S296, 2017.
Veselska R: Research Ethics Committee of the Masaryk University: first-year experience. Advanced Certificate Program in Research Ethics Network Meeting – „Transcending Borders: Building and Sustaining a Bioethics Network for Low- and Middle-Income Countries“ (Riga, Latvia), 2017.
Chlapek P, Slavikova V, Adamkova K, Sterba J, Veselska R: Analysis of putative protein markers of resistance to retinoids in neuroblastoma cells. NCRI Cancer Conference (Liverpool, UK), 2017.
Macigova P, Neradil J, Melicharkova K, Kyr M, Mudry P, Veselska R, Sterba J: Analysis of phosphorylation pattern of RTK and MAPK signaling pathways in pediatric neurogenic tumors. In: Annals of Oncology: Abstract Book of the 3rd Molecular Analysis for Personalised Therapy (MAP) – Meeting Abstract 50, 28 (Suppl. 7) (Zürich, Switzerland), p. 19, 2017.
Mikulenkova E, Veselska R: Centrosome amplification is associated with overexpression of deltaNp73 isoform in cancer cell lines of neurogenic origin. In: Centrosomes and Spindle Pole Bodies – EMBO Conference (Heidelberg, Germany), p. 172, 2017.
Macigova P, Neradil J, Melicharkova K, Kyr M, Mudry P, Veselska R, Sterba J: The use of phospho-protein arrays in the identification of possible therapeutic targets in pediatric sarcomas. In: The Biomania Student Scientific Meeting (Brno, CZ), p. 36, 2017.
Slavikova V, Chlapek P, Adamkova K, Jezova M, Mazanek P, Sterba J, Veselska R: Expression of candidate biomarkers of resistance to retinoids in relationship to the sensitivity to retinoids in neuroblastoma tumor tissue samples and tumor-derived cell lines. In: XVIII. setkani biochemiku a molekularnich biologu – Sbornik prispevku (Brno, CZ), p. 43, 2017.
Vejmelkova K, Pavelka Z, Martincekova, Melicharkova K, Jezova M, Veselska R, Zitterbart K, Kren L, Lipina R, Smrcka M, Slaby O, Sterba J: Lecba refrakternich/rekurentnich ependymomu: klinicky prospech z personalizace terapie na podklade biologickeho profilu onemocneni. In: XXVII. Konference detskych hematologu a onkologu CR a SR – Sbornik abstrakt (Prague, CZ), p. 89-90, 2017.
Ulrichova M, Melicharkova K, Zapletalova D, Jezova M, Veselska R, Slaby O, Krenova Z, Freiberger T, Kanderova V, Hrusak O, Kren L, Tuma J, Skotakova J, Sterba J: Personalizovana lecba s vyuzitim biomarkeru v klinicke praxi u relabovanych/refrakternich B-NHL. In:XXVII. Konference detskych hematologu a onkologu CR a SR – Sbornik abstrakt (Prague, CZ), p. 106-107, 2017.
Sterba J, Veselska R, Slaby O, Valik D, Mudry P, Neradil J, Melicharkova K, Kyr M, Mazanek P, Chlapek P, Slavikova V, Jezova M, Fabian P, Souckova L, Kozakova S, Pavelka Z, Demlova R, Bajciova V, Zapletalova D: Biological response modifiers with metronomic chemotherapy backbones as biomarker-driven add-on treatment strategy in very high risk pediatric solid tumors and NHLs – a single institution pilot study. In: CAC2 Pediatric Cancer Research Conference: From Bench to Bedside and Beyond (Cold Spring Harbor, NY, USA), pp. 7-8, 2016.
Sterba J, Melicharkova K, Zapletalova D, Freiberger T, Kanderova V, Hrusak O, Kren L, Tuma J, Skotakova J, Krenova Z, Veselska R, Slaby O: Theranostic approach for relapsed APDS like Burkitt lymphoma. In: CAC2 Pediatric Cancer Research Conference: From Bench to Bedside and Beyond (Cold Spring Harbor, NY, USA), p. 10, 2016.
Veselska R, Nunukova A, Skoda J, Loja T, Zambo I, Neradil J, Hermanova M, Hampl A, Sterba J: Tumorigenicity and expression of the core stem cell markers in rhabdomyosarcoma cells. In: International Journal of Molecular Medicine 38 (Suppl. 1) – the 21th World Congress on Advances in Oncology and the 19th International Symposium on Molecular Medicine (Athens, Greece), p. S54, 2016.
Chlapek P, Slavikova V, Sterba J, Veselska R: Sensitivity to the natural and synthetic retinoids in relation to the expression of selected protein markers in neuroblastoma cell lines. In: International Journal of Molecular Medicine 38 (Suppl. 1) – the 21th World Congress on Advances in Oncology and the 19th International Symposium on Molecular Medicine (Athens, Greece), p. S55, 2016.
Neradil J, Melicharkova K, Mudry P, Veselska R, Sterba J: Detailed analysis of phosphorylated receptor tyrosine kinases and downstream signaling pathways in selected pediatric malignancies. In: International Journal of Molecular Medicine 38 (Suppl. 1) – the 21th World Congress on Advances in Oncology and the 19th International Symposium on Molecular Medicine (Athens, Greece), p. S55, 2016.
Chlapek P, Slavikova V, Adamkova K, Sterba J, Veselska R: Sensitivity of neuroblastoma cell lines to retinoids in relationship to the expression of selected protein markers. In: Tumor Biology 37 (Suppl. 1) – the 43th Congress of the International Society of Oncology and Biomarkers (Chicago, USA), p. S15, 2016.
Veselska R, Skoda J, Nunukova A, Loja T, Zambo I, Neradil J, Hermanova M, Mudry P, Zitterbart K, Zapletalova D, Kyr M, Jaros J, Hampl A, Sterba J: Sox2 – a key player in tumorigenesis? In: 12th International Congress of Cell Biology – Programme and Abstract Book (Prague, Czech Republic), p. 90, 2016.
Neradil J, Melicharkova K, Kyr M, Mudry P, Veselska R, Sterba J: Phosphorylation profiling of receptor tyrosine kinases and downstream signalling pathways in pediatric malignancies as a new tool for personalized therapy. In: 12th International Congress of Cell Biology – Programme and Abstract Book (Prague, Czech Republic), p. 162, 2016.
Nunukova A, Neradil J, Skoda J, Loja T, Jaros J, Hampl A, Sterba J, Veselska R: Nuclear localization of CD133 plasma membrane glycoprotein in sarcoma cells. In: 12th International Congress of Cell Biology – Programme and Abstract Book (Prague, Czech Republic), p. 166, 2016.
Neradil J, Melicharkova K, Kyr M, Mudry P, Veselska R, Sterba J: Phospho-protein arrays: a useful tool for profiling of signaling pathways in pediatric refractory solid tumors. In: Cellular signalling and cancer therapy – EMBO Conference (Cavtat, Croatia), p.168, 2016.
Sramek M, Neradil J, Zitterbart K, Sterba J, Veselska R: Analysis of PDGF/PDGFR signaling in the infantile myofibromatosis cell line with a mutation in PDGFRB gene. In: Cellular signalling and cancer therapy – EMBO Conference (Cavtat, Croatia), p.201, 2016.
Neradil J, Melicharkova K, Mudry P, Sterba J, Veselska R: Analysis of RTK signaling pathways in alveolar rhabdomyosarcoma during the course of the disease. In: Cellular signalling and cancer therapy – EMBO Conference (Cavtat, Croatia), p.212, 2016.
Neradil J, Melicharkova K, Kyr M, Mudry P, Veselska R, Sterba J: Profilovani bunecne signalizace u pediatrickych refrakternich nadoru pomoci proteinovych arrays. In: Laboratorni diagnostika v onkologii (Brno, CZ), pp. 6-7, 2016.
Chlapek P, Slavikova V, Sterba J, Veselska R: Senzitivita vuci prirodnim a syntetickym retinoidum ve vztahu k expresi vybranych proteinovych markeru u neuroblastomovych bunecnych linii. In: Klinicka Onkologie (Suppl. 2) – XL. Brnenske onkologicke dny (Brno, CZ), p. 2S133, 2016.
Veselska R, Skoda J, Nunukova A, Loja T, Zambo I, Neradil J, Hermanova M, Mudry P, Zitterbart K, Zapletalova D, Kyr M, Jaros J, Hampl A, Sterba J: Cancer stem cell markers in pediatric sarcomas: Comparative analysis of their expression in tumor tissues and derived cell lines. In: International Journal of Molecular Medicine 36 (Suppl. 1) – the 20th World Congress on Advances in Oncology and the 18th International Symposium on Molecular Medicine (Athens, Greece), p. S71, 2015.
Neradil J, Sramek M, Mrkvicova M, Zitterbart K, Sterba J, Veselska R: Methotrexate and all-trans retinoic acid combined treatment for induction of osteosarcoma cell lines differentiation in vitro. In: Pediatric Blood & Cancer 62 (Suppl. 4) – 47th Congress Of The International Society of Paediatric Oncology (SIOP) (Cape Town, South Africa), p. S268, 2015.
Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R: Methotrexate induces epigenetic alterations in osteosarcoma cell lines. In: Pediatric Blood & Cancer 62 (Suppl. 4) – 47th Congress Of The International Society of Paediatric Oncology (SIOP) (Cape Town, South Africa), p. S269, 2015.
Skoda J, Neradil J, Zambo I, Hermanova M, Sterba J, Veselska R: Identification of cancer stem cells in osteosarcoma cell lines: characterization of cancer stem cell markers expression and in vivo tumorigenicity. In: Pediatric Blood & Cancer 62 (Suppl. 4) – 47th Congress Of The International Society of Paediatric Oncology (SIOP) (Cape Town, South Africa), p. S269, 2015.
Chlapek P, Chovanova S, Slavikova V, Sterba J, Veselska R: Hypoxia and acidosis modulate effects of combined differentiation-inducing treatment of tumor cell lines. In: EACR-OECI Conference on Precision Medicine for Cancer – Programme Book (Luxembourg City, Luxembourg), p. 26, 2015.
Veselska R: Who owns our dead bodies? In: UNESCO Chair in Bioethics 10th World Conference: Bioethics, Medical Ethics and Health Law – Program and Book of Abstracts (Jerusalem, Israel), p. 73, 2015.
Veselska R: GATTACA here and now: from science fiction to reality. In: Mendel’s legacy – 150 years of genetics genius (Brno, CZ), p. 198, 2014.
Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R: The mechanisms of methotrexate action in osteosarcoma cell lines. In: XXV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Brno, CZ), p. 63, 2015.
Veselska R, Zambo I, Skoda J, Nunukova A, Loja T, Neradil J, Mudry P, Hermanova M, Zitterbart K, Zapletalova D, Kyr M, Jaros J, Hampl A, Sterba J: Cancer stem cell markers in pediatric sarcomas: SOX2 expression correlates with tumorigenicity of cells derived from pediatric sarcomas. In: XXV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Brno, CZ), p. 67, 2015.
Skoda J, Nunukova A, Zambo I, Neradil J, Mudry P, Zitterbart K, Hermanova M, Hampl A, Sterba J, Veselska R: SOX2 expression correlates with tumorigenicity of cells derived from pediatric sarcomas. In: XXV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Brno, CZ), p. 68, 2015.
Neradil J, Melicharkova K, Kyr M, Mudry P, Veselska R, Sterba J: Protein arrays as a tool for signaling pathways profiling in pediatric refractory solid tumors. In: XXV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Brno, CZ), p. 70, 2015.
Fedorakova I, Stancokova T, Bician P, Sterba J, Veselska R, Neradil J: Embryonalny rhabdomyosarkom v orbite – cielena liecba (kazuistika). In: XXV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Brno, CZ), p. 146, 2015.
Chlapek P, Chovanova S, Slavikova V, Sterba J, Veselska R: Změny působení ATRA v kombinaci s inhibitory LOX/COX v závislosti na podmínkách simulujících nádorové mikroprostředí – studie in vitro. In: XXV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Brno, CZ), p. 151, 2015.
Mikulenkova E, Neradil J, Zitterbart K, Sterba J, Veselska R: Zvýšená exprese izoformy ∆Np73 ve vztahu k amplifikaci centrosomů v buňkách neurogenních nádorů. In: XXV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Brno, CZ), p. 160, 2015.
Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R: Methotrexate induces epigenetic alterations in osteosarcoma cell lines. In: The Biomania Student Scientific Meeting 2015 – Abstract Book (Brno, CZ), p. 54, 2015.
Chovanova S, Chlapek P, Slavikova V, Sterba J, Veselska R: Hypoxia, acidosis and glucose deprivation modulate effects of combined differentiation-inducing treatment in tumor cell lines. In: XVII. setkání biochemiků a molekulárních biologů – Abstract Book (Brno, CZ), p. 39, 2015.
Mikulenkova E, Neradil J, Zitterbart K, Sterba J, Veselska R: Association of ∆Np73 overexpression with centrosome amplification in brain tumor cell lines. In: XVII. setkání biochemiků a molekulárních biologů – Abstract Book (Brno, CZ), p. 45, 2015.
Nunukova A, Neradil J, Skoda J, Jaros J, Hampl A, Sterba J, Veselska R: Nuclear localization of CD133 molecule in rhabdomyosarcoma cell lines. In: XVII. setkání biochemiků a molekulárních biologů – Abstract Book (Brno, CZ), p. 47, 2015.
Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R: Epigenetic changes induced by methotrexate in osteosarcoma cell lines. 10th NCRI Cancer Conference (Liverpool, UK), 2014.
Chovanova S, Chlapek P, Slavikova V, Sterba J, Veselska R: Influence of hypoxia and acidosis on the neuroblastoma cells in vitro after combined treatment with all-trans retinoic acid and LOX/COX inhibitors. 10th NCRI Cancer Conference (Liverpool, UK), 2014.
Neradil J, Nunukova A, Zambo I, Hermanova M, Zitterbart K, Sterba J, Veselska R: Expression of cancer stem cels markers in rhabdomyosarcoma xenografted cell lines. In: Stem Cells and Epigenetics in Cancer – EMBO Workshop – Abstract Book (Hong Kong, China), p. 52, 2014.
Skoda J, Neradil J, Nunukova A, Nemec P, Hermanova M, Lenz J, Veselska R: Expression profile analysis of pancreatic ductal adenocarcinomas based on the presence of distinct cancer stem cells markers. In: Stem Cells and Epigenetics in Cancer – EMBO Workshop – Abstract Book (Hong Kong, China), p. 57, 2014.
Neradil J, Veselska R, Mudry P, Melicharkova K, Sterba J: Mapping of receptor tyrosine kinases activation and downstream signaling in rhabdomyosarcoma. In: International Journal of Molecular Medicine 34 (Suppl. 1) – the 19th World Congress on Advances in Oncology and the 17th International Symposium on Molecular Medicine (Athens, Greece), p. S78, 2014.
Skoda J, Neradil J, Zitterbart K, Sterba J, Veselska R: EGFR signaling in glioblastoma cells with a loss of EGFR gene copy and unusually mild clinical course of disease. In: International Journal of Molecular Medicine 34 (Suppl. 1) – the 19th World Congress on Advances in Oncology and the 17th International Symposium on Molecular Medicine (Athens, Greece), p. S78, 2014.
Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R: Methotrexate dependent changes of DNA methylation and gene expression in osteosarcoma cell lines. In: International Journal of Molecular Medicine 34 (Suppl. 1) – the 19th World Congress on Advances in Oncology and the 17th International Symposium on Molecular Medicine (Athens, Greece), p. S79, 2014.
Veselska R, Nunukova A, Skoda J, Neradil J, Jaros J, Hermanova M, Zambo I, Mudry P, Zitterbart K, Hampl A, Sterba J: Nuclear localization of CD133 in sarcoma cells. International Journal of Molecular Medicine 34 (Suppl. 1) – the 19th World Congress on Advances in Oncology and the 17th International Symposium on Molecular Medicine (Athens, Greece), p. S81, 2014.
Neradil J, Nunukova A, Kockova H, Zambo I, Hermanova M, Mudry P, Zitterbart K, Sterba J, Veselska R: Changes in expression of CSCs markers in rhabdomyosarcoma xenografted cell lines. In: Pathology – Journal of the RCPA 46 (Suppl. 2) – the XXXth Congress of the International Academy of Pathology (Bangkok, Thailand), pp. 48-49, 2014.
Mikulenkova E, Neradil J, Zitterbart K, Sterba J, Veselska R: Centrosome amplification is associated with overexpression of ΔNp73 isoform in brain tumor cell lines. In: Centrosomes and spindle pole bodies – EMBO Workshop – Abstract Book (Lisboa, Portugal), p. 189, 2014.
Chlapek P, Chovanova S, Slavikova V, Sterba J, Veselska R: Influence of hypoxic and acidic conditions on effects of combined differentiation-inducing treatment of tumor cells. In: EMBO/EMBL Symposium Frontiers in Metabolism: From Molecular Physiology to Systems Medicine – Abstracts of papers (Heidelberg, Germany), p. 81, 2014.
Nunukova A, Skoda J, Neradil J, Zitterbart K, Mudry P, Sterba J, Veselska R: Detection of cancer stem cell markers in rhabdomyosarcoma cell lines. In: Stem Cells and Cancer – 8th International Heinrich F.C. Behr Symposium – Abstract Book (Heidelberg, Germany), p. 67, 2014.
Skoda J, Rumiskova G, Neradil J, Nunukova A, Mikulenkova E, Hermanova M, Lenz J, Veselska R: Expression of CD133 and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines. In: Stem Cells and Cancer – 8th International Heinrich F.C. Behr Symposium – Abstract Book (Heidelberg, Germany), p. 78, 2014.
Nunukova A, Skoda J, Neradil J, Mudry P, Sterba J, Veselska R: Analysis of expression of cancer stem cell markers in cell lines derived from pediatric rhabdomyosarcomas. In: Cancer stem cells 20 years later: Achievements, controversies, emerging concepts and technologies – Abstract Book (Catanzaro, Italy), p. 118, 2014.
Chlapek P, Neradil J, Redova M, Zitterbart K, Sterba J, Veselska R: The ATRA-induced differentiation enhanced with LOX/COX inhibitors: an analysis of gene expression in neuroblastoma and medulloblastoma cells. In: Drug Discovery and Therapy World Congress 2014 – Abstracts (Boston, USA), p. 106, 2014.
Slavikova V, Chlapek P, Chovanova S, Sterba J, Veselska R: Vplyv hypoxie na bunkovu diferenciaciu indukovanu pomocou kyseliny all-trans retinovej a inhibitorov LOX/COX u buniek osteosarkomu. In: XXIV. Konference detskych hematologu a onkologu Ceske a Slovenske republiky (Olomouc, CZ), p. 131, 2014.
Chovanova S, Chlapek P, Slavikova V, Sterba J, Veselska R: Vliv hypoxie a acidózy na kombinované působení kyseliny all-trans retinové a inhibitorů LOX/COX v podmínkách in vitro. In: XXI. Biologicke dny – Pokroky a vyzvy soucasne nadorove biologie – Abstract Book (Brno, CZ), p. 63, 2014.
Nunukova A, Skoda J, Neradil J, Zitterbart K, Mudry P, Sterba J, Veselska R: Detekce markerů nádorových kmenových buněk v rabdomyosarkomových buněčných liniích. In: XXI. Biologicke dny – Pokroky a vyzvy soucasne nadorove biologie – Abstract Book (Brno, CZ), p. 80, 2014.
Sramek M, Neradil J, Mrkvicova M, Zitterbart K, Sterba J, Veselska R: Změny v metylaci DNA a genové expresi u osteosarkomových buněčných linií po působení metotrexátu. In: XXI. Biologicke dny – Pokroky a vyzvy soucasne nadorove biologie – Abstract Book (Brno, CZ), p. 87, 2014.
Veselska R, Mikulenkova E, Neradil J, Zitterbart K, Sterba J: Expression of deltaNp73 isoform and its association with centrosome amplification in neurogenic tumor cell lines. In: International Journal of Molecular Medicine 32 (Suppl. 1) – the 18th World Congress on Advances in Oncology and the 16th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S42, 2013.
Neradil J, Kockova H, Zambo I, Hermanova M, Husek K, Mudry P, Zitterbart K, Sterba J, Veselska R: CXCR4 expression in sarcoma derived cell lines. In: International Journal of Molecular Medicine 32 (Suppl. 1) – the 18th World Congress on Advances in Oncology and the 16th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S39, 2013.
Chlapek P, Filipova L, Zitterbart K, Sterba J, Veselska R: Medulloblastoma subcategories as identified by molecular markers differ in tumor tissue and in corresponding cell lines. In: International Journal of Molecular Medicine 32 (Suppl. 1) – the 18th World Congress on Advances in Oncology and the 16th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S39, 2013.
Zitterbart K, Stehlikova O, Kyr M, Fiamoli V, Pavelka Z, Veselska R, Sterba J: Regulatory T cells in the peripheral blood of the everolimus-treated pediatric patients with tuberous sclerosis complex and subependymal giant cell astrocytoma. In: Pediatric Blood & Cancer 60 (Suppl. S3) – 45th Congress of the International Society of Paediatric Oncology (SIOP) (Hong Kong, China), p. S56, 2013.
Skoda J, Neradil J, Zambo I, Hermanova M, Sterba J, Veselska R: Detection of CD133 in osteosarcoma cell lines. In: The 7th Symposium „Mechanisms and Models of Cancer“ – Book of Abstracts (San Diego, USA), p. 106, 2013.
Neradil J, Pavlasova G, Sramek M, Veselska R, Zitterbart K, Pilatova K, Valik D, Sterba J: Effects of methotrexate on cell lines derived from pediatric solid tumors. In: The 7th Symposium „Mechanisms and Models of Cancer“ – Book of Abstracts (San Diego, USA), p. 90, 2013.
Skoda J, Neradil J, Zitterbart K, Sterba J, Veselska R: Signalizace EGFR v bunkach multiformniho glioblastomu s neobvyklou ztratou kopie genu EGFR a mirnym klinickým prubehem onemocneni. In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 31, 2013.
Zitterbart K, Stehlikova O, Kyr M, Fiamoli V, Brichtova E, Mackerle Z, Pavelka Z, Veselska R, Sterba J: mTOR inhibice: prvni zkusenosti s uzitim everolimu k lecbe nadoru spojenych s tuberozni sklerozou na Klinice detske onkologie LF MU a FN Brno In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 32, 2013.
Chovanova S, Krzyzankova M, Chlapek P, Sterba J, Veselska R: Efekty kombinovaneho posobenia kyseliny all-trans retinovej, kyseliny kavovej a celecoxibu na osteosarkomove bunkove linie. In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 71, 2013.
Kockova H, Neradil J, Zambo I, Hermanova M, Husek K, Mudry P, Zitterbart K, Sterba J, Veselska R: Exprese receptoru CXCR4 u sarkomovych bunecenych linii. In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 73, 2013.
Mikulenkova E, Neradil J, Zitterbart K, Sterba J, Veselska R: Exprese izoformy deltaNp73 ve vztahu k amplifikaci centrosomu v bunecnych liniich derivovanych z neurogennich nadoru. In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 75, 2013.
Nunukova A, Skoda J, Neradil J, Zitterbart K, Mudry P, Sterba J, Veselska R: Detekce antigenu CD133 a jeho epitopu AC133 v rhabdomyosarkomovych bunecnych liniich. In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 77, 2013.
Skoda J, Neradil J, Zambo I, Hermanova M, Sterba J, Veselska R: Detekce CD133 u osteosarkomovych bunecnych linii. In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 78, 2013.
Chlapek P, Filipova L, Zitterbart K, Sterba J, Veselska R: Identifikace podskupin meduloblastomu pomoci molekularnich markeru u nadorovych tkani a z nich odvozenych bunecnych linii. In: XXIII. Konference detských hematologu a onkologu Ceske a Slovenske republiky (Ostrava, CZ), p. 78, 2013.
Chovanova S, Krzyzankova M, Chlapek P, Sterba J, Veselska R: Efekty kombinovaneho posobenia kyseliny all-trans retinovej, kyseliny kavovej a celecoxibu na osteosarkomove bunkove linie. In: Sborník abstrakt – XXXVII. Brněnské onkologické dny a XXVII. Konference pro nelékařské zdravotnické pracovníky (Brno, CZ), p. 79, 2013.
Veselska R, Zambo I, Skoda J, Hermanova M, Neradil J, Sana J, Chlapek P, Zitterbart K, Mudry P, Hampl A, Sterba J: Expression of CD133 and nestin in sarcomas. In: Tumor Biology 33 (Suppl. 1) – the 40th Congress of the International Society of Oncology and Biomarkers (Jerusalem, Israel), p. 20, 2012.
Chlapek P, Redova M, Neradil J, Zitterbart K, Hermanova M, Sterba J, Veselska R: COMBAT in vitro: Enhancement of the retinoid-induced cell differentiation by LOX/COX inhibitors in cell lines derived from pediatric solid tumors. In: Tumor Biology 33 (Suppl. 1) – the 40th Congress of the International Society of Oncology and Biomarkers (Jerusalem, Israel), p. 120, 2012.
Zambo I, Hermanova M, Krakorova Adamkova D, Mudry P, Zitterbart K, Kyr M, Vesely K, Sterba J, Veselska R: Analysis of nestin expression in pediatric and adult cases of high-grade osteosarcoma. In: Virchows Archiv 461 (Suppl. 1) – the 24th European Congress of Pathology (Prague, CZ), p. S136, 2012.
Skoda J, Neradil J, Sana J, Zambo I, Chlapek P, Hermanova M, Mudry P, Vasikova A, Zitterbart K, Hampl A, Sterba J, Veselska R: Expression of CD133 and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines. In: Stem Cells and Cancer – 7th International Heinrich F.C. Behr Symposium – Abstract Book (Heidelberg, Germany), p. 100, 2012.
Krzyzankova M, Chovanova S, Sterba J, Veselska R: Synergistic effects of all-trans retinoic acid and celecoxib on different sarcoma cell lines. In: 9th NCRI Cancer Conference – Abstract Book (Liverpool, UK), p. B161, 2012.
Veselska R: Teaching of Research Ethics: A Ten-year Experience from Masaryk University (Czech Republic). In: 8th International Conference on Bioethics Education: Contents, Methods, Trends – Abstract Book (Kinar, Israel), p. 186, 2012.
Veselska R, Hulova V: Teaching research ethics to Czech and Slovak students: Experience form the Masaryk University. Seven years of capacity-building in Central and Eastern Europe and beyond: The network meeting of the Advanced certificate program in research ethics for Central and Eastern Europe (Prague, CZ) 2012.
Neradil J, Skoda J, Sana J, Zambo I, Chlapek P, Hermanova M, Mudry P, Vasikova A, Zitterbart K, Hampl A, Sterba J, Veselska R: Exprese CD133a identifikace CD133/nestin pozitivních buněk u rabdomyosarkomů a rabdomyosarkomových buněčných liniích. In: XXII. Konferencia detskych hematologov a onkologov Ceskej a Slovenskej republiky – program a zbornik abstraktov (Bratislava, Slovakia), p. 87, 2012.
Sterba J, Zitterbart K, Pavelka Z, Mackerle Z, Veselska R, Skotakova J: Současné možnosti léčby relapsů meduloblastomu u dětí. In: XXII. Konferencia detskych hematologov a onkologov Ceskej a Slovenskej republiky – program a zbornik abstraktov (Bratislava, Slovakia), 2012.
Mikulenkova E, Neradil J, Zitterbart K, Sterba J, Veselska R: Exprese N-terminalnich izoforem proteinu p73 v buněčných liniích derivovaných z neurogenních nádorů s aberantním počtem centrozomů. In: Onkologie 6 (Suppl. B) – VIII. Dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), p. B34, 2012.
Pavlasova G, Neradil J, Veselska R, Zitterbart K, Pilatova K, Valik D, Sterba J: Analyza ucinku metotrexatu na bunecne linie ze solidnich nadoru detskeho veku. In: Onkologie 6 (Suppl. B) – VIII. Dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), pp. B35-B36, 2012.
Veselska R, Zitterbart K, Nekulova M, Dobrucka L, Neradil J, Chlapek P, Sterba J: Intracellular distribution of N-terminal isoforms of the p73 protein in medulloblastoma cell lines. In: International Journal of Molecular Medicine 28 (Suppl. 1) – 16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine (Rhodes, Greece), p. S50, 2011.
Chlapek P, Redova M, Neradil J, Zitterbart K, Hermanova M, Sterba J, Veselska R: Changes in gene expression in neuroblastoma and medulloblastoma cell lines during induced differentiation by combined treatment with all-trans retinoic acid and LOX/COX inhibitors. In: International Journal of Molecular Medicine 28 (Suppl. 1) – 16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine (Rhodes, Greece), p. S13, 2011.
Skoda J, Neradil J, Loja T, Zitterbart K, Pavelka Z, Brichtova E, Smardova J, Valaskova I, Hermanova M, Sterba J, Veselska R: Analysis of HGG-02 cell line with loss of EGFR gene copy derived from childhood glioblastoma multiforme. In: International Journal of Molecular Medicine 28 (Suppl. 1) – 16th World Congress on Advances in Oncology and 14th International Symposium on Molecular Medicine (Rhodes, Greece), p. S36, 2011.
Hermanova M, Zambo I, Sana J, Skoda J, Neradil J, Chlapek P, Mudry P, Vasikova A, Zitterbart K, Sterba J, Veselska R: Identification of cells with cancer stem cell phenotype in rhabdomyosarcoma. In: Virchows Archive 459 (Suppl 1) – 23rd European Congress of Pathology (Helsinki, Finland), p. S316, 2011.
Zitterbart K, Dobrucka L, Chlapek P, Neradil J, Skoda J, Sterba J, Veselska R: N-terminal p73 protein isoforms in medulloblastoma cells and their involvement in retinoic acid-induced differentiation. In: Pediatric Blood & Cancer 57 (5) – 43rd Congress of the International Society of Paediatric Oncology (Auckland, New Zealand), p. 807, 2011.
Chlapek P, Redova M, Neradil J, Zitterbart K, Hermanova M, Sterba J, Veselska R: Expresni profily bunecnych linii derivovanych z neuroblastomu a meduloblastomu po kombinovane aplikaci all-trans retinove kyseliny a LOX/COX inhibitoru. In: Geneticka konference GSGM 2011 – Konferencni sbornik (Lednice, CZ), p. 78, 2011.
Zambo I, Hermanova M, Adamkova Krakorova D, Mudry P, Zitterbart K, Kyr M, Vesely K, Sterba J, Veselska R: Klinicko-patologicke aspekty exprese nestinu v high-grade osteosarkomech. In: Onkologie 5 (Suppl. B) – VII. Dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), p. B19, 2011.
Skoda J, Neradil J, Loja T, Zitterbart K, Pavelka Z, Brichtova E, Smardova J, Valaskova I, Hermanova M, Sterba J, Veselska R: Analysis of HGG-02 cell line with loss of EGFR gene copy derived from childhood glioblastoma multiforme. In: Onkologie 5 (Suppl. B) – VII. Dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), p. B47, 2011.
Chlapek P, Redova M, Neradil J, Zitterbart K, Hermanova M, Sterba J, Veselska R: Changes in gene expression in neuroblastoma and medulloblastoma cell lines during induced differentiation by combined treatment with all-trans retinoic acid and LOX/COX inhibitors. In: Onkologie 5 (Suppl. B) – VII. Dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), p. B48, 2011.
Lenz J, Karasek P, Jarkovsky J, Muckova K, Dite P, Kala Z, Veselska R, Hermanova M: Klinicko-patologicke korelace exprese nestinu ve tkáni duktalniho adenokarcinomu pankreatu vcetne perineuralniho sireni. In: Onkologie 5 (Suppl. B) – VII. Dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), p. B48-49, 2011.
Chlapek P, Redova M, Neradil J, Zitterbart K, Hermanova M, Sterba J, Veselska R: Expression profiling of neuroblastoma and medulloblastoma cell lines after combined treatment by all-trans retinoic acid and LOX/COX inhibitors. In: The Student Scientific Conference on Cancer Research – Conference book (Brno, CZ), p. 74, 2011.
Dobrucka L, Neradil J, Chlapek P, Sterba J, Veselska R, Zitterbart K: Intracellular localization of p73 N-terminal isoforms in medulloblastoma cell lines and differences induced with retinoic acid. In: The Student Scientific Conference on Cancer Research – Conference book (Brno, CZ), p. 98, 2011.
Veselska R, Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J: Enhancement of retinoid-induced cell differentiation in cancer therapy. In: International Journal of Molecular Medicine 26 (Suppl. 1) – 15th World Congress on Advances in Oncology and 13th International Symposium on Molecular Medicine (Loutraki, Greece), p. S38, 2010.
Chlapek P, Redova M, Zitterbart K, Hermanova M, Sterba J, Veselska R: Expression profilig of neuroblastoma and medulloblastoma cell lines after combined treatment by all-trans retinoic acid and LOC/COX inhibitors. In: International Journal of Molecular Medicine 26 (Suppl. 1) – 15th World Congress on Advances in Oncology and 13th International Symposium on Molecular Medicine (Loutraki, Greece), p. S39, 2010.
Zitterbart K, Nekulova M, Sterba J, Veselska R: Intracellular localization of TAp73 and ΔNp73 protein isoforms in medulloblastoma cell lines. In: Neuro-Oncology 12 – 14th International Symposium on Pediatric Neuro-Oncology (Vienna, Austria), p. ii51, 2010.
Veselska R: Dlazba z dobrych umyslu. In: 14. celostatni konference DNA diagnostiky – sbornik abstrakt (Brno, CZ), p. 47, 2010.
Neradil J, Skoda J, Loja T, Zitterbart K, Pavelka Z, Smardova J, Valaskova I, Hermanova M, Sterba J, Veselska R: Ztrata kopie genu pro EGFR u pacienta s multiformnim glioblastomem: pripadova studie a analyza derivovane linie. In: XX. konference detskych hematologu a onkologu Ceske a Slovenske republiky – program konference a sbornik abstrakt (Prague, CZ), p. 105, 2010.
Dobrucka L, Nekulova M, Neradil J, Chlapek P, Sterba J, Veselska R, Zitterbart K: Exprese N-koncovych izoforem proteinu p73 v bunecnych liniich meduloblastomu. In: XX. konference detskych hematologu a onkologu Ceske a Slovenske republiky – program konference a sbornik abstrakt (Prague, CZ), p. 106, 2010.
Sana J, Chlapek P, Zitterbart K, Sterba J, Veselska R: Exprese CD133 a nestinu v bunecnych liniich derivovanych z rhabdomyosarkomu. In: XXXIV. Brnenske onkologicke dny – edukacni sbornik (Brno, CZ), pp. 287-289, 2010.
Krupkova O, Mozna E, Zitterbart K, Sterba J, Veselska R: Subcelularni lokalizace nestinu v nadorove transformovanych bunkach. In: XXXIV. Brnenske onkologicke dny – edukacni sbornik (Brno, CZ), pp. 281-282, 2010.
Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R: LOX/COX inhibitors may potentiate the antineoplastic effect of retinoids: in vitro study in neuroblastoma and medulloblastoma cell lines. In: Genes and Cancer – 26th Meeting (Coventry, UK), p. 75, 2009.
Chlapek P, Redova M, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R: Expression profiling of neuroblastoma cell lines after combined treatment with all-trans retinoic acid and LOX/COX inhibitors. In: Genes and Cancer – 26th Meeting (Coventry, UK), p. 42, 2009.
Veselska R, Hermanova M, Sana J, Loja T, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J: Cancer stem cell markers in selected childhood tumors of mesenchymal origin. In: International Journal of Molecular Medicine 24 (Suppl. 1) – 14th World Congress on Advances in Oncology and 12th International Symposium on Molecular Medicine (Loutraki, Greece), p. S37, 2009.
Zitterbart K, Kantorova D, Filkova H, Zezulkova D, Necesalova E, Slamova I, Vranova V, Tomasikova L, Pesakova M, Oltova A, Pavelka Z, Sterba J, Kuglik P, Veselska R: Copy number changes of MYCC and MYCN genes detected by I-FISH are useful prognostic markers in children with medulloblastoma: A study from the University Hospital Brno. In: International Journal of Molecular Medicine 24 (Suppl. 1) – 14th World Congress on Advances in Oncology and 12th International Symposium on Molecular Medicine (Loutraki, Greece), p. S37, 2009.
Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R: LOX/COX inhibitors: possible way to potentiate the antineoplastic effect of retinoids in neuroblastoma and medulloblastoma cell lines. In: International Journal of Molecular Medicine 24 (Suppl. 1) – 14th World Congress on Advances in Oncology and 12th International Symposium on Molecular Medicine (Loutraki, Greece), p. S33, 2009.
Zitterbart K, Filkova H, Zezulkova D, Necesalova E, Slamova I, Vranova V, Tomasikova L, Pesakova M, Oltova A, Kantorova D, Pavelka Z, Veselska R, Sterba J, Kuglik P: Low level gain of MYCC and MYCN has prognostic impact in children with medulloblastoma. In: 2nd Midsummer Meeting on Pediatric Hematology, Oncology and Stem Cell Transplantation (Piechowice, Poland), 2009.
Filkova H, Zitterbart K, Tomasikova L, Vranova V, Zezulkova D, Kantorova D, Kuglik P, Pavelka Z, Sterba J, Veselska R: Prognostic signification of copy number changes of MYCN and MYCC genes studied by I-FISH method in childhood medulloblastoma. In: Chromosome Research 17 (Suppl. 1) – 7th European Cytogenetics Conference (Stockholm, Sweden), p.124, 2009.
Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R: Studie moznosti ovlivneni antineoplastickeho efektu retinoidu jejich kombinovanou aplikaci s LOX/COX inhibitory na modelu neuroblastomovych bunecnych linií. In: XIX. Konferencia detskych hematologov a onkologov Ceskej a Slovenskej republiky – zbornik abstraktov (Kosice, Slovakia), p. 69, 2009.
Zitterbart K, Filkova H, Tomasikova L, Zezulkova D, Necesalova E, Vranova V, Slamova I, Pesakova M, Kantorova D, Zambo I, Veselska R, Oltova A, Pavelka Z, Kuglik P, Rutkowski S, Sterba J: Prognosticke biomarkery meduloblastomu: zarazeni pacientu do rizikovych skupin v nastupujici generaci lecebnych protokolu. In: XIX. Konferencia detskych hematologov a onkologov Ceskej a Slovenskej republiky – zbornik abstraktov (Kosice, Slovakia), p. 48, 2009.
Veselska R, Hermanova M, Loja T, Sana J, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J: Identifikace nestin/CD133 pozitivnich bunek v solidnich nadorech mesenchymalniho puvodu. In: XXXIII. Brnenske onkologicke dny – edukacni sbornik (Brno, CZ), p. 81, 2009.
Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R: Moznosti modulace ATRA-indukovane diferenciace neuroblastomovych a meduloblastomovych bunecnych linii pusobenim LOX/COX inhibitoru. In: XXXIII. Brnenske onkologicke dny – edukacni sbornik (Brno, CZ), pp. 30-31, 2009.
Zitterbart K, Filkova H, Kantorova D, Zezulkova D, Necesalova E, Slamova I, Vranova V, Tomasikova L, Pesakova M, Oltova A, Pavelka Z, Veselska R, Sterba J, Kuglik P: Pocetni zmeny genu MYCN a MYCC stanovene metodou I-FISH maji prognosticky vyznam u deti s meduloblastomem: analyza nadoroveho materialu pacientu Kliniky detske onkologie LF MU a FN Brno. In: XXXIII. Brnenske onkologicke dny – edukacni sbornik, pp. 82-83, 2009.
Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J: The identification of cells with cancer stem cell phenotype in osteosarcomas. In: International Journal of Molecular Medicine 22 (Suppl. 1) – 13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S49, 2008.
Veselska R, Redova M, Chlapek P, Loja T, Hermanova M, Sterba J, Zitterbart K: The influence of LOX/COX inhibitors on the ATRA-induced differentiation in neuroblastoma cell lines. In: International Journal of Molecular Medicine 22 (Suppl. 1) – 13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S55, 2008.
Zezulkova D, Kuglik P, Stefancikova L, Filkova H, Vranova V, Mazanek P, Sterba J, Zitterbart K, Veselska R: Cytogenetic changes and clinical outcome in neuroblastoma: A study from the University Hospital Brno. In: International Journal of Molecular Medicine 22 (Suppl. 1) – 13th World Congress on Advances in Oncology and 11th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S49, 2008.
Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J: Identifikace markeru nádorovych kmenovych bunek v osteosarkomech. In: XVIII. konference detskych hematologu a onkologu Ceske a Slovenske republiky – sbornik abstrakt (Plzen, CZ), p. 47, 2008.
Veselska R, Redova M, Chlapek P, Loja T, Hermanova M, Zitterbart K, Sterba J: Vliv LOX/COX inhibitoru na ATRA-indukovanou diferenciaci na modelu neuroblastomových a meduloblastomových bunecnych linii. In: XVIII. konference detskych hematologu a onkologu Ceske a Slovenske republiky – sbornik abstrakt (Plzen, CZ), p. 102, 2008.
Loja T, Chlapek P, Hermanova M, Zambo I, Vesely K, Zitterbart K, Sterba J, Veselska R: The identification of cells with cancer stem cell phenotype in pediatric solid tumors. In: XIX. Biologicke dny – Biologicky vyzkum pro lidske zdravi (Hradec Kralove, CZ), p. 49, 2008.
Redova M, Chlapek P, Loja T, Zitterbart K, Hermanova M, Sterba J, Veselska R: Modulation of the antineoplastic effect of retinoids in neuroblastoma and medulloblastoma cell lines. In: XIX. Biologicke dny – Biologicky vyzkum pro lidske zdravi (Hradec Kralove, CZ), p. 21, 2008.
Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I, Zitterbart K, Sterba J: Detekce markeru nadorovych kmenovych bunek u osteosarkomu. In: Edukacni sborník – XXXII. Brnenske onkologicke dny (Brno, CZ), p. 91, 2008.
Veselska R: Ethical aspects of genetic testing. In: Ethics in Clinical Trials – Book of Abstracts (Prague, CZ), p. 49, 2007.
Veselska R, Loja T, Chlapek P, Hermanova M, Zavrelova I, Zitterbart K, Sterba J: Nestin as a biomarker of transformed cells in solid tumors and tumor cell lines. European Biomarker Summit (Amsterdam, Netherlands) 2007.
Cejpek P, Kuglik P, Veselska R, Necesalova E, Vranova V, Relichova J, Krupa P, Horky J, Vnencak P: Significance of molecular cytogenetic characterization of glioblastoma. In: EANS Congress Programme (Glasgow, UK), p.22, 2007.
Veselska R, Loja T, Chlapek P, Hermanova M, Zavrelova I, Zitterbart K, Sterba J: Exprese a intracelularni lokalizace nestinu v solidnich nadorech a v nadorovych bunecnych liniich. In: XVII. konference detskych hematologu a onkologu Ceske a Slovenske republiky (Spindleruv Mlyn, CZ), p.115, 2007.
Zezulkova D, Vranova V, Kuglik P, Stefancikova L, Filkova H, Necesalova E, Jarosova M, Mazanek P, Veselska R, Sterba J: Geneticke zmeny u neuroblastomu stredniho a vysokeho rizika a jejich prognosticky význam. In: XVII. konference detskych hematologu a onkologu Ceske a Slovenske republiky (Spindleruv Mlyn, CZ), pp.130-131, 2007.
Zitterbart K, Necesalova E, Zavrelova I, Zezulkova D, Filkova H, Lentvorska L, Vranova V, Slamova I, Pavelka Z, Sterba J, Kuglik P, Veselska R: Vztah vybranych cytogenetickych markeru k histopatologickemu vysetreni a prognoze u pacientu s meduloblastomem. In: XVII. konference detskych hematologu a onkologu Ceske a Slovenske republiky (Spindleruv Mlyn, CZ), pp.123-124, 2007.
Redova M, Chlapek P, Loja T, Krupkova O, Zitterbart K, Sterba J, Veselska R: Nove derivovane bunecne linie ze solidnich nadoru: zakladni charakterizace a pilotni studie vlivu LOX/COX inhibitoru na proliferacni aktivitu. In: XVII. konference detskych hematologu a onkologu Ceske a Slovenske republiky (Spindleruv Mlyn, CZ), pp.121-122, 2007.
Zezulkova D, Vranova V, Kuglik P, Stefancikova L, Filkova H, Necesalova E, Jarosova M, Mazanek P, Veselska R, Sterba J: Geneticka charakterizace neuroblastomu stredního a vysokého rizika pomoci metod FISH, CGH a array-CGH. In: Celostatni sjezd Spolecnosti lekarske genetiky CSL JEP a 40. vyrocni cytogeneticka konference (Prague, CZ), 2007.
Necesalova E, Zitterbart K, Zezulkova D, Filkova H, Pavlik T, Zavrelova I, Lentvorska L, Vranova V, Slamova I, Pavelka Z, Sterba J, Kuglik P, Veselska R: Detekce prognosticky vyznamnych cytogenetickych markeru u meduloblastomu s vyuzitim metod CGH a I-FISH. In: Edukacni sbornik – XXXI. Brnenske onkologicke dny (Brno, CZ), pp. 158-161, 2007.
Veselska R, Kuglik P, Zitterbart K, Loja T, Vranova V, Necesalova E, Kepak T: Molecular cytogenetics in diagnosis of embryonal childhood tumors. In: International Journal of Molecular Medicine 18 (Suppl. 1) – 11th World Congress on Advances in Oncology and 9th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S65, 2006.
Loja T, Chlapek P, Zitterbart K, Veselska R: Re-exprese nestinu v nadorove transformovanych bunkach: in vitro studie na vybranych typech solidnich nadoru. In: II. dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), p. 40, 2006.
Kuglik P, Vranova V, Necesalova E, Zezulkova D, Stefancikova L, Filkova H, Mazanek P, Sterba J, Veselska R: Moznosti komparativni genomove hybridizace s vyssim rozlisenim (HR-CGH) a array-CGH pri detekci prognostickych markeru u neuroblastomu. In: II. dny diagnosticke, prediktivni a experimentalni onkologie (Olomouc, CZ), pp. 39-40, 2006.
Loja T, Veselska R: Nestin as a marker of transformed cells in brain tumors. In: XIV. Cytoskeletalni klub (Nove Mesto na Morave, CZ), p. 16, 2006.
Veselska R, Loja T, Cejpek P, Neradil J, Svachova H, Kuglik P, Relichova J: Nestin distribution pattern in GM7 glioblastoma cells. In: Cellular and Molecular Biology 51, (Suppl.) – 4th World Congress of Cell and Molecular Biology (Poitiers, France), p. 127, 2005.
Veselska R: What has been patented so far? In: Models of Governance of the Human Genome – Workshop II: Patenting and Group Consent; PropEur = Property Regulation in European Science, Ethics and Law (Bilbao, Spain), p.2, 2005.
Necesalova E, Vranova V, Kuglik P, Cejpek P, Veselska R, Pesakova M: Molekularne cytogeneticke vysetreni multiformniho glioblastomu. 38. vyrocni konference Cytogeneticke sekce CSBS (Brno, CZ), 2005.
Necesalova E, Vranova V, Kuglik P, Cejpek P, Pesakova M, Veselska R: Nejcastejsi chromosomove zmeny u multiformniho glioblastomu detekovane pomoci molekularne cytogenetickych technik. Onkogenetika – satelitni symposium veletrhu Hospimedica (Brno, CZ), 2005.
Cejpek P, Kuglik P, Krupa P, Veselska R, Novak, Chrastina, Riha, Necesalova E, Pesakova, M, Horky J, Relichova J: Vyznam cytogenetiky a molekularni genetiky pro strategii diagnostiky a lecby glioblastomu z pohledu neurochirurga. Onkogenetika – satelitni symposium veletrhu Hospimedica (Brno, CZ), 2005.
Loja T, KuglIk P, Veselska R: Optimalizacia prípravy a spracovanie molekularne cytogenetickych preparatov pre spektralne karyotypovanie. In: Mikroskopie 2005 – sbornik prednasek a abstraktu (Nove Mesto na Morave, CZ), p.40, 2005.
Veselska R, Kuglik P, Cejpek P, Hublarova P, Svachova H, Relichova J: Nestin expression in cell lines derived from high-grade astrocytomas. In: International Journal of Molecular Medicine (Suppl. 1) – 9th World Congress on Advances in Oncology and 7th International Symposium on Molecular Medicine (Hersonissos, Greece), p. S21, 2004.
Veselska R, Kuglik P, Cejpek P, Hublarova P, Svachova H, Dvorakova E, Neradil J, Relichova J: Establishment and characterization of a new cell line derived from human high-grade astrocytoma. In: 9th European Workshop on Cytogenetics and Molecular Genetics of Human Solid Tumours – Book of Abstracts (Brno, CZ), p. 78, 2004.
Cejpek P, Kuglik P, Veselska R, Pesakova M, Krupa P, Relichova J, Vybihal V, Mlejnek P, Lzicarova E, Horky J: Molecular cytogenetic characterization of glioblastoma using the technique of fluorescence in situ hybridization, comparative genomic hybridization and spectral karyotyping. In: 9th European Workshop on Cytogenetics and Molecular Genetics of Human Solid Tumours – Book of Abstracts (Brno, CZ), p. 54, 2004.
Veselska R, Zitterbart K, Auer J, Neradil J: Caffeic acid enhances differentiation of HL-60 myeloid leukemia cells induced by all-trans retinoic acid. In: Journal of Molecular Histology 35 – 40th Annual Symposium of the Czech Society of Cytochemistry and Histochemistry (Hradec Kralove, CZ), pp. 203-204, 2004.
Neradil J, Veselska R, Svoboda A: Apoptosis during induced neuronal differentiation of EC cell line P19. In: Journal of Molecular Histology 35 – 40th Annual Symposium of the Czech Society of Cytochemistry and Histochemistry (Hradec Kralove, CZ), p. 194, 2004.
Veselska R, Kuglik P, Hublarova P, Svachova H, Lzicarova E, Cejpek P, Relichova J: Nestin expression in cell lines derived from high-grade astrocytomas. In: X. Cytoskeletalni klub (Vranovska Ves, CZ), p. 13, 2003.
Neradil J, Veselska R, Svoboda A: Actin as a substrate for activated caspase-3. In: X. Cytoskeletalni klub (Vranovska Ves, CZ), p. 12, 2003.
Neradil J, Veselska R, Zitterbart K, Svoboda A: Specific alterations of actin cytoskeleton during apoptosis. In: X. Cytoskeletalni klub (Vranovska Ves, CZ), p. 30, 2003.
Veselska R, Kuglik P, Hublarova P, Svachova H, Relichova J, Cejpek P: Kultivace bunek solidnich tumoru in vitro pro ucely geneticke diagnostiky. In: Sbornik abstrakt – Kongres MEFA: Symposium Genova diagnostika a terapie solidnich tumoru (Brno, CZ), 2003.
Cejpek P, Kuglik P, Krupa P, Veselska R, Sedlackova M, Relichova J, Vybihal V, Mlejnek P, Lzicarova E, Horky J: Genova diagnostika multiformniho glioblastomu. In: Sbornik abstrakt – Kongres MEFA: Symposium Genova diagnostika a terapie solidnich tumoru (Brno, CZ), 2003.
Kuglik P, Veselska R, Hublarova P, Svachova H, Sedlackova M, Oltova A, Relichova J, Cejpek P: Molecular cytogenetic and immunochemical study of high-grade astrocytomas. In: Annales de Genetique 46 – 4th European Cytogenetics Conference (Bologna, Italy), p. 164, 2003.
Kuglik P, Sedlackova M, Veselska R, Oltova A, Kupska R, Relichova J, Cejpek P: Molecular cytogenetic characterisation of glioblastoma multiforme by fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH) and spectral karyotyping. In: European Journal of Human Genetics 11 (Suppl.) – European Human Genetics Conference (Birmingham, UK), p. 80, 2003.
Kuglik P, Sedlackova M, Veselska R, Oltova A, Kupska R, Relichova J, Cejpek P: Molekularne cytogeneticka charakterizace multiformniho glioblastomu pomoci techniky fluorescencni hybridizace in situ, komparativni genomove hybridizace a spektralniho karyotypovani. In: Edukacni sbornik XXVII. Brnenskych onkologickych dnu (Brno, CZ), pp. 106-107, Brno 2003.
Koutna M, Veselska R, Janisch R: Changes in cell proliferation after low-power laser irradiation. In: XVIIth Biological Days – Memory in Living Systems (Brno, CZ), p. 59, 2003.
Veselska R, Zitterbart K, Auer J: Induced differentiation and apoptosis in HL-60 cell line modulated by caffeic acid treatment. In: 10th Euroconference on Apoptosis – „Charming to Death“ (Paris, France), p. P-166, 2002.
Neradil J, Veselska R, Zitterbart K, Svoboda A: The role of actin cytoskeleton in apoptotic cell death. In: 10th Euroconference on Apoptosis – „Charming to Death“ (Paris, France), p. P-98, 2002.
Janisch R, Veselska R, Skorpikova J: Cytoskeleton response to manipulation stress. In: Microscopy, Czechoslovak Microscopy Society (Brno, CZ), pp. 27-30, 2002.
Veselska R, Zitterbart K, Auer J: Caffeic acid affects an induced differentiation process into granulocyte stage in HL-60 myeloid leukaemia cell line. In: Cells IV – Book of Abstracts (Ceske Budejovice, CZ), p. 90, 2002.
Neradil J, Veselska R, Svoboda A: Changes in the cytoskeleton of P19 cells during apoptosis associated with induced differentiation. In: Cells IV – Book of Abstracts (Ceske Budejovice, CZ), p. 108, 2002.
Veselska R, Neradil J, Zitterbart K, Svoboda A: The role of actin in the apoptotic cell death. In: X. Cytoskeletalni klub (Vranovska Ves, CZ), p. 18, 2002.
Veselska R, Neradil J, Zitterbart K, Svoboda A: Changes in the cytoskeleton of HL-60 and P19 cells during apoptosis associated with differentiation process. In: X. Cytoskeletalni klub (Vranovska Ves, CZ), p. 29, 2002.
Veselska R, Neradil J, Zitterbart K, Svoboda A: Changes in the cytoskeleton during apoptotic cell death. In: 9th Euroconference on Apoptosis (Vienna, Austria), p. P75, 2001.
Veselska R, Neradil J, Zitterbart K, Svoboda A: Zmeny cytoskeletu behem procesu apoptozy. In: XVI. Biologicke dny – Aktualni temata z bunecne a molekularni biologie (Olomouc, CZ), p. 35, 2001.
Veselska R: Cytoskelet bunek myeloidni leukemicke linie HL-60 ve vztahu k indukci apoptózy a diferenciace. In: IX. Cytoskeletalni klub (Vranovska Ves, CZ), p. 17, 2001.
Zitterbart K, Veselska R, Jelinkova S, Svoboda A: Zmeny cytoskeletu bunek linie HL-60 v prubehu apoptozy indukovane kyselinou all-trans retinovou. In: IX. Cytoskeletalni klub (Vranovska Ves, CZ), p. 31, 2001.
Veselska R, Janisch R: Reaction of the skin fibroblasts cytoskeleton to micromanipulation. In: Cellular and Molecular Biology 46 – 3rd World Congress of Cellular and Molecular Biology (Jena, Germany), p. 256, 2000.
Zitterbart K, Veselska R, Jelinkova S, Svoboda A: Changes in cytoskeleton of HL-60 cells during induced apoptosis. In: Cellular and Molecular Biology 46 – 3rd World Congress of Cellular and Molecular Biology (Jena, Germany), p. 278, 2000.
Veselska R, Zitterbart K, Jelinkova S, Svoboda A: Changes in actin cytoskeleton of promyelocytic leukemia HL-60 cell line during induced differentiation and apoptosis. In: Cells II – Book of Abstracts (Ceske Budejovice, CZ), p. 125, 2000.
Veselska R, Janisch R: Reaction of the actin cytoskeleton of human skin fibroblasts as the result of micromanipulation treatment. In: Cells II – Book of Abstracts (Ceske Budejovice, CZ), p. 165, Ceske Budejovice 2000.
Veselska R, Janisch R: Vliv mikromanipulaci na cytoskelet lidskych koznich fibroblastů linie KF-1. In: VIII. Cytoskeletalni klub (Vranovska Ves, CZ), p. 18, 2000.
Davidova P, Veselska R: Zmeny mikrotubulů bunek linie HL-60 v důsledku kombinovaneho působeni ultrazvuku a vybranych cytostatik. In: VIII. Cytoskeletalni klub (Vranovska Ves, CZ), p. 29, 2000.
Veselska R, Halackova Z: In vitro cytotoxicity evaluation of the root canal cones and sealers. In: 3rd World Congress on Alternatives and Animal Use in the Life Sciences – Amendments to the Scientific Programme (Bologna, Italy), pp. 12-13, 1999.
Veselska R, Neradil J: The influence of the short wavelength ultraviolet irradiation on cytoskeleton and proliferation activity of human skin cells in vitro. In: Cells – Book of Abstracts (Ceske Budejovice, CZ), p. 143, 1999.
Veselska R, Neradil J: Vliv kratkovlnneho UV zareni na cytoskelet a proliferaci lidskych koznich fibroblastů in vitro. In VII. Cytoskeletalni klub (Vranovska Ves, CZ), p. 35, 1999.
Veselska R, Janisch R: Changes in the cytoskeleton and viability of L929 fibroblasts following UV irradiation. XIV. In: Folia Biologica 44 – Biological Days (Prague, CZ), p. S17-0, 1998.
Veselska R, Janisch R, Neradil J: Zmeny cytoskeletu lidskych epidermoidnich bunek A431 v důsledku UV ozareni. In: Prirodovedec 34 – Biologicke dni (Nitra, Slovakia), pp. 120-121, 1998.
Skorpikova J, Veselska R, Dolnikova M, Janisch R, Hrazdira I: Cytoskeleton alteration and proliferation activity due to ultrasound and cytostatics. In: Prirodovedec 34 – Biologicke dni (Nitra, Slovakia), pp. 97-98, 1998.
Veselska R, Halackova Z, Kukletova M: Cytotoxicity of gutta percha cones and endodontic sealers. In: Journal of Dental Research 77 – 76th General Session of the International Association for Dental Research (Nice, France), p. 691, 1998.
Veselska R, Halackova Z: Cytotoxicita gutapercovych cepů a sealerů. In: Interdental – Mezinarodni stomatologicka konference (Bratislava, Slovakia), pp. 12-14, 1997.
Veselska R, Janisch R: Vliv UV zareni na strukturu mikrotubulů v mysich fibroblastech. In: V. Cytoskeletalni klub (Vranovska Ves, CZ), p. 33, Praha 1997.
Kuglik P, Veselska R, Relichova J: Sensitivity of plant cytogenetic and genetic short-term assays for evaluating genetic damage induced by chemical mutagens. In: Cell Biology International – IV. European Cell Biology Congress (Prague, CZ), p. 543, 1994.
Kuglik P, Veselska R: Moznosti testovani mutagenity environmentalnich polutantů pomoci detekce SCE v buňkach Vicia faba. In: 17. pracovni dny Spolecnosti pro mutagenezu zevnim prostredim (Brno, CZ), 1994.
Chroust K, Kuglik P, Relichova J, Holoubek I, Caslavsky J, Veselska R, Ryskova M, Benedik J: Genotoxicity comparison of environmental pollutants in Drosophila melanogaster, Vicia faba and Arabidopsis thaliana. In: 13th European Drosophila Research Conference (Heraklion, Greece), 1993.
Veselska R, Kuglik P, Relichova J: Moznosti detekce genotoxickeho pusobeni alkylacnich latek kratkodobymi rostlinnymi genetickymi a cytogenetickymi testy. In: Geneticka konference GSGM (Brno, CZ), p. 19, 1993.
Veselska R, Kuglik P, Relichova J: The comparison of plant genetic and cytogenetic short-termed assays for the evaluation of genetic damage induced by chemical mutagens. In: TOCOEN Conference (Znojmo, CZ), 1993.
Kuglik P, Chroust K, Relichova J, Veselska R, Ryskova M, Benedik J: The comparison of Arabidopsis thaliana, Vicia faba and Drosophila melanogaster bioassays for the detection of mutagens in environment. In: TOCOEN Conference (Znojmo, CZ), 1993.
Kuglik P, Veselska R: Characterization of a cytogenetic adaptive response induced by gamma-radiation in Vicia faba root tip cells. In: Folia Biologica 38 (Suppl.) – Czechoslovak Conference on Radiation Biology (Brno, CZ), S14-15, 1992.
Kuglik P, Veselska R: K moznosti navozeni radio-adaptivni odpovedi v meristematickych buňkach Vicia faba. In: Biological Days (Brno, CZ), 1992.
Kuglik P, Dobricka R, Slotova J: Mikrojaderny test jako biologicky indikator ucinku malych davek ionizujiciho zareni. In: Mezinarodni vystava techniky pro tvorbu a ochranu zivotniho prostredi ENVIBRNO (Brno, CZ), 1990.
Kuglik P, Dobricka R, Slotova J: Adaptivni odpoved v meristematickych buňkach Vicia faba. In: Celostatna radiobiologicka konferencia (Tatranska Lomnica, Slovakia), 1990.
Kuglik P, Dobricka R, Slotova J: Adaptivni odpoved stimulovana malymi davkami ionizujiciho zareni v meristematickych buňkach Vicia faba. In: Program a suhrny referatov z celostatnej radiobiologickej konferencie (Kosice, Slovakia), p. 35, 1990.
Kuglik P, Slotova J, Dobricka R: Cytogeneticke důsledky působeni nizkych davek ionizujiciho zareni na chromosomy bunek Vicia faba. In: III. konferencia mladych vedeckych pracovnikov Univerzity Komenskeho a Medzinarodneho sympózia biotechnológie a ochrany a tvorby zivotneho prostredia (Bratislava, Slovakia), 1988.